Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 29,350 shares at $68.84 ($2.0M) on 2023-10-02, disclosed to the SEC on 2023-10-02.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |